- Acquired by Tokai Pharmaceuticals, May 2017
- Raised $4.3M Series A led by OrbiMed, Jan 2012
- Raised $650k Seed round, Dec 1969
About
Otic Pharma Ltd. was a clinical-stage pharmaceutical company focused on developing therapeutic products for ear, nose, and throat (ENT) disorders. Their lead investigational drug, FoamOtic Externa, was a foam-based version of ciprofloxacin, an antibiotic, designed for the treatment of acute otitis externa (AOE, or "swimmer's ear"). The company's proprietary FoamOtic platform aimed to provide sustained drug exposure, fewer administrations, and lower doses. Otic Pharma also had other pipeline products in development, including FoamOtic Sinus for chronic sinusitis, Foam-O-Vet for otitis externa in dogs, and FoamOtic Media for the treatment of otitis media. Otic Pharma's leading product was a nasally administered drug for treating the underlying cause of otitis media and Eustachian tube dysfunction (OM/ETD).
Funding history · 4 rounds · $5.0M total
Q&A
- What is Otic Pharma's primary focus?
- Otic Pharma develops therapeutic products for ear, nose, and throat (ENT) disorders, utilizing a proprietary FoamOtic platform.
- What is Otic Pharma's leading investigational drug?
- Otic Pharma's leading investigational drug is FoamOtic Externa, a foam-based version of ciprofloxacin, which is being prepared for a Phase III clinical trial for acute otitis externa (AOE, or "swimmer's ear").
- What are some other pipeline products based on Otic Pharma's FoamOtic platform?
- Other pipeline products based on the FoamOtic platform include FoamOtic Sinus for chronic sinusitis, Foam-O-Vet for otitis externa in dogs, and FoamOtic Media for the treatment of otitis media.
- When was Otic Pharma founded?
- Otic Pharma was founded in January 2008.
- How many employees does Otic Pharma have?
- Otic Pharma has 1-10 employees.
- What is Otic Pharma's total funding raised?
- Otic Pharma has raised a total of $5,246,000 USD.
- Which investors participated in Otic Pharma's June 2009 funding round?
- Peregrine Ventures participated in Otic Pharma's funding round in June 2009.
- Which investor participated in Otic Pharma's February 2012 funding round?
- OrbiMed participated in Otic Pharma's funding round in February 2012.
- Which investors participated in Otic Pharma's May 2015 funding round?
- OrbiMed and Pontifax participated in Otic Pharma's funding round in May 2015.
- What is Otic Pharma's current status?
- Otic Pharma is currently active, but was acquired by Novus Therapeutics in May 2017.
Team · 3
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | oticpharma.com |
|---|---|
| linkedin.com/company/6973010 |
Identifiers & details
| Legal name | Otic Pharma Ltd. |
|---|---|
| Founded | 2008-1 |
| Offices | Irvine |
| Status reason | Acquired (Inactive) by Novus Therapeutics on May 2017 - closed due to acquisition |
Acquisitions & public offerings
Acquired by Tokai Pharmaceuticals 2017-05
Radar intelligence
Patents
| EPO | 9 |
|---|
Web history (Wayback)
| Domain | oticpharma.com |
|---|
Certificate / subdomain footprint
| Subdomains | 0 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514090638 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2008-01-23 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2020 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | אופנהיימר 7 רחובות |